HLH-2004 Diagnostic Criteria (Hemophagocytic Lymphohistiocytosis)

The HLH-2004 diagnostic criteria for hemophagocytic lymphohistiocytosis (Henter and colleagues 2007, Table I).

Open the calculator → Runs in your browser. Data leaves only if you deliberately send a problem report from the interactive tool.

Example

A molecular diagnosis consistent with HLH
No
Fever
Yes
Splenomegaly
Yes
Hemophagocytosis in bone marrow, spleen or lymph nodes
Yes
Infant under 4 weeks old
No
Hemoglobin
8 g/dL
Platelets
50 x10^9/L
Neutrophils
2 x10^9/L
Fasting triglycerides
300 mg/dL
Fibrinogen
200 mg/dL
The other 5 values
NK-cell activity LOW OR ABSENT by local laboratory reference
Pending / not done
Ferritin
900 ug/L
Whether the soluble CD25 assay has returned
Resulted
Soluble CD25
5000 U/mL
No evidence of malignancy
Yes

Result: 7

The tool opens with these values already filled in. Replace them with your own.

What the result means

Two paths
EITHER a molecular diagnosis consistent with HLH, OR 5 of 8 criteria. The molecular path establishes the diagnosis with ZERO criteria.
Ninth bullet
"No evidence of malignancy" is printed in the table but is NOT one of the eight. Counting it gives nine.
Fever
The primary gives NO temperature threshold. The 38.5 degrees C figure in secondary tables is not in the source.
Cytopenias
ONE criterion requiring 2 of 3 lineages: Hb under 9 g/dL (under 10 in infants under 4 weeks), platelets under 100, neutrophils under 1.0 x10^9/L.
Lipids
ONE criterion, an OR: triglycerides 265 mg/dL or above, and/or fibrinogen 150 mg/dL or below.
Ferritin
500 micrograms/L or above; micrograms/L and ng/mL are numerically identical.
sCD25
2400 U/mL or above. A send-out assay.
NK activity
Low or absent BY LOCAL LABORATORY REFERENCE. No universal cutoff.
Pending
PENDING IS NOT NOT-MET. 4 met plus 2 pending does NOT exclude HLH. Untreated HLH is rapidly fatal.
Scope
Criteria from a treatment protocol. Not an instruction to start etoposide. Does not identify the trigger. Not the HScore.

What you enter

  • A molecular diagnosis consistent with HLH.
  • Fever.
  • Splenomegaly.
  • Hemophagocytosis in bone marrow, spleen or lymph nodes.
  • Infant under 4 weeks old, which raises the hemoglobin threshold from 9 to 10 g/dL.
  • Hemoglobin.
  • Platelets.
  • Neutrophils.
  • Fasting triglycerides.
  • Fibrinogen.
The other 5 fields
  • A molecular diagnosis consistent with HLH. THIS IS AN ALTERNATIVE PATH: yes establishes the diagnosis on its own, with none of the eight criteria.
  • Fever. The primary table gives NO temperature threshold; the 38.5 degrees C figure in secondary tables is not in the source.
  • Splenomegaly. No size threshold is given in the source.
  • Hemophagocytosis in bone marrow, spleen or lymph nodes. Its absence at presentation does not exclude HLH; the source encourages a further search.
  • Hemoglobin. Counts as a low lineage under 9 g/dL (source 90 g/L), or under 10 in infants under 4 weeks.
  • Platelets. Counts as a low lineage under 100 x10^9/L.
  • Neutrophils. Counts as a low lineage under 1 x10^9/L. 2 of the 3 lineages must be low for the single cytopenia criterion.
  • Fasting triglycerides. Meets at 265 mg/dL or above (source 3.0 mmol/L). Shares ONE criterion with fibrinogen: either alone satisfies it.
  • Fibrinogen. Meets at 150 mg/dL or BELOW (source 1.5 g/L). Shares one criterion with triglycerides.
  • NK-cell activity LOW OR ABSENT by local laboratory reference. There is no universal cutoff, so the local laboratory verdict is the input. A send-out assay: use "pending" if it has not returned.
  • Ferritin. Meets at 500 micrograms/L or above; micrograms/L and ng/mL are numerically identical.
  • Whether the soluble CD25 assay has returned. "pending" makes the criterion UNEVALUABLE and the number is ignored - pending is not the same as not met.
  • Soluble CD25 (soluble IL-2 receptor). Meets at 2400 U/mL or above. A send-out assay: use "pending" if it has not returned.
  • No evidence of malignancy. REPORTED BUT NOT COUNTED - it is printed in the primary table but is not one of the eight criteria.
How this is calculated

Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124-131, Table I. Read the source ↗

A reference and educational tool. Not medical, legal, or financial advice, and not a substitute for clinician judgment.

Browse all tools

Built by Clay Good. Source on GitHub.